Manfred P. Lutz - Concepedia

Author

Manfred P. Lutz

Universität Ulm ORCID

Also Known As

João Freire, Lutz, Lutz, Manfred P, Lutz, Manfred P., M Lutz, M P Lutz, M. Lutz, M. P. Lutz, M., Lutz, M.P Lutz

204

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Universität Ulm cts CaritasKlinikum Saarbrücken Heidelberg University Hôpital Ambroise-Paré European Organisation for Research and Treatment of Cancer

About

Manfred P. Lutz is an author at Universität Ulm specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	44	3K
2	Health Sciences	9	9	832
3	Natural Sciences	2	2	42
4	Engineering	1	1	15
5	Nursing	1	1	144

Manfred P. Lutz

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer Alberto Sobrero, Joan Maurel, Louis Fehrenbacher, Journal of Clinical Oncology	2008	945
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954 Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, Journal of Clinical Oncology	2010	704
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004) Theo J. M. Ruers, Cornelis J.A. Punt, Frits van Coevorden, Annals of Oncology Surgical OncologyHepatologyRadiation TherapyRadiofrequency AblationMedicine	2012	434
Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986 Claus Henning Köhne, Eric Van Cutsem, J. Wils, Journal of Clinical Oncology	2005	329
Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study Jean–Luc Van Laethem, Pascal Hammel, F. Mornex, Journal of Clinical Oncology	2010	294
Overexpression and Activation of the Tyrosine Kinase Src in Human Pancreatic Carcinoma Manfred P. Lutz, I.B.Silke Eßer, Berenike B.M. Flossmann-Kast, Biochemical and Biophysical Research Communications Cancer ResearchSignal TransductionPancreatic CancerTyrosine Kinase SrcMedicine	1998	248
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma Gunnar Folprecht, Manfred P. Lutz, Patrick Schöffski, Annals of Oncology OncologyMedicineColorectal CancerPathologyIrinotecan/5-fluorouracil/folinic Acid	2005	233
Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. André Menke, Christian Philippi, Roger Vogelmann, PubMed Cell AdhesionPathologyCollagen Type IvCancer BiologyTumor Biology	2001	198
Randomized Phase III Study of High-Dose Fluorouracil Given As a Weekly 24-Hour Infusion With or Without Leucovorin Versus Bolus Fluorouracil Plus Leucovorin in Advanced Colorectal Cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952 C-H Köhne, J. Wils, M. Lorenz, Journal of Clinical Oncology	2003	158
Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer – Differential treatment strategies for subtypes of early gastroesophageal cancer Manfred P. Lutz, John Zalcberg, Michel Ducreux, European Journal of Cancer Surgical OncologyEsophagusEsophageal CancerGastrointestinal OncologyMedicine	2012	152

Page 1